Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine in Autism
NCT00627705Phase 2Completed
- Sponsor
- Stanford University
- Start
- Feb 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Started Feb 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00627705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627705.